Track topics on Twitter Track topics that are important to you
Company ranked 6th in 2017 and in Top 10 for Third Year Running
Incyte Corporation (Nasdaq:INCY) today announced it has been ranked 6th on Forbes magazine’s 2017 list of the World’s Most Innovative Companies. Incyte, a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, is advancing an innovative and diverse portfolio of large and small molecules comprised of 17 development candidates against 14 different molecular targets.
“It is an honor to be recognized as one of the World’s Most Innovative Companies by Forbes year-after-year,” said Hervé Hoppenot, Incyte’s Chief Executive Officer. “At Incyte, innovation is in our DNA. We push ourselves every day to be at the forefront of advancing science as we research and develop treatments that will positively impact the lives of patients around the world.”
Forbes’ ranking is based on the companies’ “innovation premium,” and only includes industries that are known to invest in innovation and businesses that have at least seven years of financial data and a market value greater than $10 billion.
To view the complete list, visit http://www.forbes.com/innovative-companies/list/.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...